Regulatory Updates

FDA, EMA, TGA and global regulatory developments

#ANDA083667 ×

Regulatory Updates

Sep 25, 2026•1 min read

FDA Discontinues Testosterone Enanthate Injectable Products (ANDA083667)

The FDA has discontinued two injectable testosterone enanthate products from Watson Labs, listed under ANDA083667.